Clinical Research Protocol Writing Design

Each protocol is developed through a collaborative partnership with the sponsor to effectively address and achieve the trial's unique requirements and objectives.

The importance of protocol design cannot be understated, as it governs the precise manner in which a study is carried out. Richmond Pharmacology's Advanced Research Science Department possesses extensive expertise in crafting Clinical Study Protocols in accordance with ICH guidelines. Each protocol is meticulously developed through close collaboration with the Sponsor, ensuring that it effectively meets the trial's specific requirements and objectives.

All protocols are written by Richmond Pharmacology’s Advanced Research Science team, with input from Richmond Pharmacology’s Research Physicians and Principal Investigators.

Why Choose Richmond Pharmacology?

- Expertise
- Efficiency
- Collaborative Approach
- ICH Compliance
- Proven Success

Get In Touch

Don't hesitate to
reach out to us today and unlock a world of possibilities for your project. Our expert team is ready to collaborate with you, address your questions, and tailor our solutions to meet your unique needs. Your research goals are within reach, and we're here to help you achieve them. Get in touch with us now and embark on a journey towards groundbreaking discoveries. Your success story starts with a simple click or call.

Our experienced Clinical Research Scientists are dedicated to ensuring that your study design not only aligns with your specified endpoints but also achieves them through the most efficient and effective methods.

Get in touch today

Latest news


May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event